Sulesomab

We can tell you that Sulesomab is a…

• …Drug
• …Medical Treatment

If you know more about Sulesomab, you can add more facts here »

Similar topics in Freebase

• Mepolizumab

  Mepolizumab (proposed trade name Bosatria) is a humanized monoclonal antibody that recognizes interleukin-5 (IL-5), and is used to treat certain kinds of asthma and white blood cell diseases. Recent studies have concluded that mepolizumab may improve exacerbations in patients with severe...

• Igovomab

  Igovomab (trade name Indimacis-125) was a mouse monoclonal antibody for the diagnosis of ovarian cancer. Linked to the chelating agent DTPA and labelled with Indium-111, it was used for imaging (radio-immuno scintigraphy) of the cancer. The drug is no longer available.

• Efungumab

  Efungumab (trade name Mycograb) is a human monoclonal antibody developed by NeuTec Pharma (a subsidiary of Novartis), intended to treat invasive Candida infection in combination with amphotericin B. The European Medicines Agency has twice refused to grant marketing authorization for Mycograb,...

• Lexitumumab

• Priliximab

  Priliximab (cMT 412) is a human-mouse chimeric anti-CD4 monoclonal antibody. It has been tested on patients with Crohn's disease and multiple sclerosis but has not yet received U.S. Food and Drug Administration licencing. The patent belongs to the biotechnology company Centocor.

• Atlizumab

  Atlizumab is a humanized monoclonal antibody which is used as an immunosuppressive drug.

• Libivirumab

  Libivirumab is a human monoclonal antibody directed against the hepatitis B virus.

• Motavizumab

  Motavizumab (proposed INN, trade name Numax) is a humanized monoclonal antibody. It is being investigated by MedImmune (today a subsidiary of AstraZeneca) for the prevention of respiratory syncytial virus infection in high-risk infants. As of September 2009, it is undergoing Phase II and III...

• Ertumaxomab

  Ertumaxomab (trade name Rexomun) is a rat-murine hybrid monoclonal antibody designed to treat some types of cancer. As of September 2009, a Phase II clinical trial evaluating the treatment of breast cancer is recruiting participants. It works by linking T-lymphocytes and macrophages to the cancer...

• Regavirumab

  Regavirumab is a human monoclonal antibody against infections with cytomegalovirus.